Back to top
more

Molina Healthcare (MOH)

(Delayed Data from NYSE)

$155.13 USD

155.13
2,007,250

-2.74 (-1.74%)

Updated Aug 1, 2025 03:59 PM ET

After-Market: $155.05 -0.08 (-0.05%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.75%
2Buy17.82%
3Hold9.58%
4Sell5.28%
5Strong Sell2.61%
S&P50011.30%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

5-Strong Sell of 5         5

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

  • Value Score A
  • Growth Score A
  • Momentum Score A
  • VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

A Value F Growth C Momentum C VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Bottom 1% (245 out of 246)

Industry: Medical - HMOs

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Zacks News

Zacks Equity Research

Here's Why Investors Should Retain Molina Healthcare (MOH) Now

by Zacks Equity Research

Molina Healthcare (MOH) is well-poised for improvement on the back of membership growth in the Medicaid and Medicare businesses. Acquisitions and a solid cash balance act as added tailwinds.

Zacks Equity Research

Are You a Growth Investor? This 1 Stock Could Be the Perfect Pick

by Zacks Equity Research

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

Zacks Equity Research

Is Molina Healthcare (MOH) Stock Undervalued Right Now?

by Zacks Equity Research

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

Zacks Equity Research

Zacks Industry Outlook Highlights UnitedHealth, The Cigna, Humana, Centene and Molina Healthcare

by Zacks Equity Research

UnitedHealth, The Cigna, Humana, Centene and Molina Healthcare are part of the Zacks Industry Outlook article.

Zacks Equity Research

Tenet (THC) to Divest 3 Hospitals to Novant to Reduce Debt

by Zacks Equity Research

Tenet (THC) expects the divestment of the three South Carolina hospitals to fetch around $2.4 billion in cash.

Debasmita Chatterjee headshot

5 HMO Stocks Set to Gain From Growing Membership, Tech Advancements

by Debasmita Chatterjee

Rising premiums, contract wins, a telehealth services suite and the M&A strategy are expected to drive the performances of the Zacks Medical-HMO industry players. UNH, CI, HUM, CNC and MOH are poised to benefit from encouraging industry prospects.

Zacks Equity Research

Is Molina (MOH) a Solid Growth Stock? 3 Reasons to Think "Yes"

by Zacks Equity Research

Molina (MOH) could produce exceptional returns because of its solid growth attributes.

Zacks Equity Research

Zacks.com featured highlights Modine Manufacturing, Everest Group, Hilton Worldwide and Molina Healthcare

by Zacks Equity Research

Modine Manufacturing, Everest Group, Hilton Worldwide and Molina Healthcare have been highlighted in this Screen of The Week article.

Zacks Equity Research

Encompass Health (EHC) Opens Second Hospital in Wisconsin

by Zacks Equity Research

The inpatient rehabilitation hospital's opening in Fitchburg, WI, was moved up from the initially scheduled first quarter of 2024.

Sumit Singh headshot

Pick These 4 Stocks With Excellent Interest Coverage Ratio

by Sumit Singh

A company that is capable of generating earnings well above its interest expense can withstand financial hardship. MOD, EG, HLT and MOH are sound enough to meet financial obligations.

Zacks Equity Research

Molina Healthcare, Inc (MOH) Hits Fresh High: Is There Still Room to Run?

by Zacks Equity Research

Molina (MOH) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.

Zacks Equity Research

HCA Healthcare (HCA) Unveils Ambitious 5-Year Growth Targets

by Zacks Equity Research

Over the five-year horizon, HCA Healthcare (HCA) anticipates substantial 8-12% annual growth in earnings per share.

Zacks Equity Research

Is Centene (CNC) Stock Undervalued Right Now?

by Zacks Equity Research

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

Zacks Equity Research

Brookdale Senior (BKD) Shares Rise 1.9% Despite Q3 Earnings Miss

by Zacks Equity Research

Brookdale Senior (BKD) expects adjusted EBITDA to be within the $77-$82 million range in the fourth quarter.

Zacks Equity Research

Select Medical (SEM) Stock Down 6.6% Despite Q3 Earnings Beat

by Zacks Equity Research

Select Medical (SEM) continues to expect adjusted EBITDA to be between $795 million and $825 million in 2023.

Zacks Equity Research

Are You a Value Investor? This 1 Stock Could Be the Perfect Pick

by Zacks Equity Research

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

Zacks Equity Research

Cigna (CI) Q3 Earnings Beat on Membership Growth, '23 EPS View Up

by Zacks Equity Research

Cigna's (CI) Q3 results benefit on well-performing U.S. Commercial and Medicare Advantage businesses. Management currently expects 2023 adjusted EPS to be a minimum of $24.75.

Zacks Equity Research

Humana (HUM) Q3 Earnings Beat on Strong Individual MA Unit

by Zacks Equity Research

Humana (HUM) continues to project 2023 adjusted EPS at a minimum of $28.25, which suggests growth from the 2022 figure of $25.88.

Zacks Equity Research

Molina (MOH) is an Incredible Growth Stock: 3 Reasons Why

by Zacks Equity Research

Molina (MOH) possesses solid growth attributes, which could help it handily outperform the market.

Zacks Equity Research

Encompass Health's (EHC) Q3 Earnings Beat on Discharge Growth

by Zacks Equity Research

Encompass Health's (EHC) Q3 results benefit from an increase in patient volumes and net patient revenue per discharge. Management currently projects adjusted EPS to be within $3.41-$3.52 for 2023.

Zacks Equity Research

Molina Healthcare (MOH) Q3 Earnings Beat on Membership Growth

by Zacks Equity Research

Molina Healthcare's (MOH) third-quarter results gain from changes in the member mix and a growing premium base. Management reiterates its 2023 adjusted EPS guidance to be a minimum of $20.75.

Zacks Equity Research

Universal Health (UHS) Q3 Earnings Beat on Adjusted Patient Days

by Zacks Equity Research

Universal Health (UHS) has a leftover repurchase capacity of around $580 million as of Sep 30, 2023.

Zacks Equity Research

Here's What Key Metrics Tell Us About Molina (MOH) Q3 Earnings

by Zacks Equity Research

While the top- and bottom-line numbers for Molina (MOH) give a sense of how the business performed in the quarter ended September 2023, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.

Zacks Equity Research

Molina (MOH) Q3 Earnings and Revenues Beat Estimates

by Zacks Equity Research

Molina (MOH) delivered earnings and revenue surprises of 3.70% and 2.94%, respectively, for the quarter ended September 2023. Do the numbers hold clues to what lies ahead for the stock?

Zacks Equity Research

Centene (CNC) Q3 Earnings Beat on Commercial Growth, View Raised

by Zacks Equity Research

Centene (CNC) anticipates adjusted EPS to register a minimum of $6.60 this year.